ENTO ENTERO THERAPEUTICS INC Business Restructuring 8-K Filing 2025 - Debt Restructuring On May 8, 2025, Entero Therapeutics, Inc. reported a settlement agreement where ImmunogenX, LLC agreed to pay $5.5 million to Mattress Liquidators Inc. to settle obligations of approximately $7.9 million, effective April 9, 2025, along with a revolving loan of $2,436,338.30.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC